Role of Thrombolysis in Free-Flap Salvage

ABSTRACT

Approximately 5 percent of microvascular free-tissue transfers fail; often this is due to microvascular or peri-anastomotic thrombosis. Various reports have advocated the use of thrombolytics for salvage of these flaps, although clinical evidence supporting this approach is sparse. The authors attempted to review their own and other published results and present an algorithm for the use of thrombolytics in the management of failing free flaps.

A retrospective review of 590 free flaps, revealed 71 (12 percent) requiring re-exploration for impending flap failure, determined by standard clinical indicators. Forty-four (62 percent) were found to have pedicle thrombosis and 20 (28 percent) received thrombolysis with streptokinase or urokinase. All 44 flaps were grouped by final outcome and thrombolytic use for comparison.

In 24 (55 percent) of the flaps with evidence of thrombosis, the use of thrombolytics was felt to be inappropriate or unnecessary; 13 (54 percent) of these were salvaged. Twenty flaps, however, did receive thrombolysis and 6 (30 percent) of these were salvaged. There was no statistically significant difference among groups with respect to preoperative risk factors, age, gender, flap type, and site of anastomotic thrombosis. There was a twofold higher use of vein grafts in the failed vs. salvaged flaps (36 percent vs. 15.7 percent), and no flaps with vessel grafts were salvaged with thrombolytics. Despite the fact that all flaps were re-explored within 3 hr of a problem being detected, the mean time from the initial operation to re-exploration was significantly higher in flaps that did not respond to thrombolytics (63. 8 vs. 32.8 hr, respectively, p=0.0457). Also, the mean time to re-exploration was significantly higher in the salvaged flaps receiving thrombolysis vs. those that did not (32.8 vs. 22.3 hr, respectively, p=0.0264).

While early detection and re-exploration are crucial for salvaging failing free flaps, those flaps unresponsive to other standard interventions may benefit from the selective use of thrombolytics.

KEYWORDS

Failing free-tissue transfers - thrombolytics - retrospective review

REFERENCES

• 1 Salemark L. International survey of current microvascular practices in free transfer and replantation surgery.  Microsurgery . 1991;  12 308-311
• 2 Kroll S S, Schusterman M A, Reece G P. et al . Timing of pedicle thrombosis and flap loss after free-tissue transfer.  Plast Reconstr Surg . 1998;  98 1230-1233
• 3 Khouri R K, Cooley B C, Kunselman A R. et al . A prospective study of microvascular free-flap surgery and outcome.  Plast Reconstr Surg . 1998;  102 711-721
• 4 Hidalgo D A, Jones C S. The role of emergent exploration in free tissue transfer: a review of 150 consecutive cases.  Plast Reconstr Surg . 1996;  86 492-498
• 5 Johnson P C, Barker J H. Thrombosis and antithrombotic therapy in microvascular surgery.  Clin Plast Surg . 1992;  19 799-807
• 6 Acland R. Thrombus formation in microvascular surgery: an experimental study of the effects of surgical trauma.  Surgery . 1973;  73 766-771
• 7 Esclamado R M, Carroll W R. The pathogenesis of vascular thrombosis and its impact in microvascular surgery.  Head Neck . 1999;  21 355-362
• 8 Wechselberger G, Schoeller T, Ohler K. et al . Flap salvage in a “flow through” flap by manual thrombectomy plus thrombolytic therapy.  J Reconstr Microsurg . 1998;  14 127-129
• 9 Tonks A. Streptokinase salvage of a rectus abdominis free flap. Correspondence.  Plast Reconstr Surg . 1995;  95 933-934
• 10 Lipton H, Jupiter J. Streptokinase salvage of a free tissue transfer: case report and review of the literature.  Plast Reconstr Surg . 1987;  79 977-981
• 11 Serletti J M, Moran S L, Orlando G S. et al . Urokinase protocol for free-flap salvage following prolonged venous thrombosis.  Plast Reconstr Surg . 1998;  102 1947-1953
• 12 Fudem G M, Walton R L. Microvascular thrombolysis to salvage a free flap using human recombinant tissue plasminogen activator.  J Reconstr Microsurg . 1989;  5 231-234
• 13 Atiyeh B S, Hashim H A, Hamdan A M, Musharafieh R S. Local recombinant tissue plasminogen activator (rt-PA) thrombolytic therapy in microvascular surgery.  Microsurgery . 1999;  19 265-271
• 14 Romano J, Biel M. Thrombolysis in microvascular surgery using tissue-type plasminogen activator.  Arch Otolaryngol Head Neck Surg . 1989;  115 1318-1322
• 15 Goldberg J A, Pederson W C, Barwick W J. Salvage of free tissue transfers using thrombolytic agents.  J Reconstr Microsurg . 1989;  5 351-356
• 16 Yii N W, Evans G R, Miller M J. et al . Thombolytic therapy: what is its role in free flap salvage?.  Ann Plast Surg . 2001;  46 601-604
• 17 Shaw W W. Microvascular free flaps: the first decade.  Clin Plast Surg . 1983;  10 3-20
• 18 Hobby J A. Fibrinolytic activity in vascular grafts.  Plast Reconstr Surg . 1978;  61 97-100
• 19 Puckett C, Misholy H, Reinisch J. The effects of streptokinase on ischemic flaps.  J Hand Surg . 1983;  8 101-104
• 20 Jacobs G R, Reinisch J F, Puckett C L. Microvascular fibrinolysis after ischemia: its relation to vascular patency and tissue survival.  Plast Reconstr Surg . 1981;  68 737-741
• 21 Wulf R J, Mutz E T. Studies on plasminogen VIII. Species specificity of streptokinase.  Can J Biochem . 1969;  47 927-931
• 22 Lepore D A, Knight K R, Bhattacharya S. et al . Drug mixture which improves the survival of ischemic rabbit epigastric skin flaps.  Microsurgery . 1994;  15 685-692
• 23 Shubert W, Hunter D W, Guzman-Stein G. et al . Use of streptokinase for the salvage of a free flap: a case report and review of the use of thrombolytic therapy.  Microsurgery . 1987;  8 117-121
• 24 Noordanus R P, Hage J J. Late salvage of a “free flap” phalloplasty: a case report.  Microsurgery . 1993;  14 599-600
• 25 Dotter C T, Rosch J, Seaman A J. Selective clot lysis with low dose streptokinase.  Radiology . 1974;  111 31-37
• 26 Marder V J, Sherry S. Thrombolytic therapy: current status.  N Engl J Med . 1988;  318 1512-1520
• 27 Ouriel K, Welch E L, Shortell C K. et al . Comparison of streptokinase, urokinase and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis.  J Vasc Surg . 1995;  22 593-597
• 28 Stein B, Foster V. Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism.  Am J Cardiol . 1989;  64 33B-40B
• 29 Stein B, Foster V, Halperin J L. et al . Antithrombotic therapy in cardiac disease.  Circulation . 1989;  80 1501-1513
• 30 Wheatley M J, Meltzer T R. The role of vascular pedicle thrombectomy in the management of compromised free tissue transfers.  Ann Plast Surg . 1996;  36 360-364
• 31 Shaw W W, Hidalgo D A. Anastomotic technique and vein grafts.  In Microsurgery in Trauma. Mount Kisco N.Y.: Futura 1987: pp37-58